Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-18 | Protagonist Therapeutics, Inc | Ali Asif
(Chief Financial Officer) |
S | Common Stock | D | 1234 | $25.11 - $25.11 | $30,985 |
2024-04-01 | Protagonist Therapeutics, Inc | PATEL DINESH V PH D
(President and CEO) |
S | Common Stock | D | 25000 | $28.31 - $28.31 | $707,750 |
2024-03-07 | Protagonist Therapeutics, Inc | SELICK HAROLD E
(Director) |
M | Common Stock | A | 6490 | $1.89 - $1.89 | $12,266 |
2024-03-01 | Protagonist Therapeutics, Inc | PATEL DINESH V PH D
(President and CEO) |
S | Common Stock | D | 30000 | $31.62 - $31.62 | $948,600 |
2024-03-01 | Protagonist Therapeutics, Inc | Waddill William D.
(Director) |
S | Common Stock | D | 12975 | $31.34 - $31.34 | $406,636 |
2024-03-01 | Protagonist Therapeutics, Inc | Waddill William D.
(Director) |
M | Common Stock | A | 12975 | $6.09 - $6.09 | $79,017 |
2024-02-29 | Protagonist Therapeutics, Inc | Ali Asif
(Chief Financial Officer) |
S | Common Stock | D | 24187 | $30.61 - $32.33 | $764,364 |
2024-03-01 | Protagonist Therapeutics, Inc | Ali Asif
(Chief Financial Officer) |
M | Common Stock | A | 12000 | $12.17 - $12.17 | $146,040 |
2024-02-26 | Protagonist Therapeutics, Inc | PATEL DINESH V PH D
(President and CEO) |
F | Common Stock | D | 10915 | $29.53 - $29.53 | $322,319 |
2024-02-26 | Protagonist Therapeutics, Inc | Gupta Suneel
(Chief Development Officer) |
F | Common Stock | D | 4282 | $29.53 - $29.53 | $126,447 |
2024-02-15 | Protagonist Therapeutics, Inc | PATEL DINESH V PH D
(President and CEO) |
F | Common Stock | D | 3717 | $28.23 - $28.23 | $104,930 |
2024-01-16 | Protagonist Therapeutics, Inc | MOLINA ARTURO MD
(Chief Medical Officer) |
F | Common Stock | D | 427 | $24.63 - $24.63 | $10,517 |
2024-01-16 | Protagonist Therapeutics, Inc | Ali Asif
(Chief Financial Officer) |
F | Common Stock | D | 1452 | $24.63 - $24.63 | $35,762 |
2024-01-09 | Protagonist Therapeutics, Inc | Gupta Suneel
(Chief Development Officer) |
S | Common Stock | D | 5000 | $25.00 - $25.00 | $125,000 |
2024-01-09 | Protagonist Therapeutics, Inc | Gupta Suneel
(Chief Development Officer) |
M | Common Stock | A | 5000 | $7.38 - $7.38 | $36,900 |
2023-11-15 | Protagonist Therapeutics, Inc | MOLINA ARTURO MD
(Chief Medical Officer) |
S | Common Stock | D | 1848 | $16.24 - $16.24 | $30,011 |
2024-01-02 | Protagonist Therapeutics, Inc | Gupta Suneel
(Chief Development Officer) |
A | Common Stock | A | 19250 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |